Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Routine rehab vs shock wave therapy for scapular dyskinesis

Official title: Routine Rehabilitation Versus Shock Wave Therapy for Patients With Scapular Dyskinesis

Run by Tanta University · NCT07633340 · Data updated 2026-11-12

This study tests whether adding radial extracorporeal shock wave therapy to standard rehabilitation helps people with scapular dyskinesis more than rehabilitation alone.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment100 (estimated)
SponsorTanta University
Academic / other
Locations1 site (Tanta)
StatusRecruiting
StartedJune 1, 2026
Main results expectedNovember 2026
Study endsNovember 2026
Registry record updatedSeptember 30, 2026
Trial IDNCT07633340 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults with scapular dyskinesis lasting at least 6 months who have not had recent shoulder or thorax trauma or surgery and do not have listed contraindications.

Probably not a fit

Patients with contraindications to shock wave therapy or those who do not respond to rehabilitation may not benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

In this prospective, double-blind, placebo-controlled trial, participants with scapular dyskinesis are randomized to receive either active radial extracorporeal shock wave therapy (rESWT) once weekly for four weeks plus standard stretching, or sham rESWT plus standard stretching. The randomization uses closed envelopes, and participants are blinded to their group. Outcomes focus on scapular movement and related symptoms to determine if rESWT provides additional benefit over routine rehab. Exclusion criteria rule out recent shoulder or thorax trauma, neurologic deficits, inflammatory conditions, and certain contraindications to shock wave therapy. The trial is conducted at Tanta University, with 100 enrolled adults.

Why it matters

Potential benefit: If successful, adding rESWT could improve shoulder mechanics and reduce symptoms for people with scapular dyskinesis.

How similar studies have gone: Previous studies have explored shock wave therapy as a supplementary approach for shoulder-related conditions, with mixed results depending on specifics of the condition and protocol.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* This study included 100 patients with scapular dyskinesis. The patients were divided into 2 groups: one group was treated with ESWT and routine rehabilitation, and the second group was treated with routine rehabilitation only. Adult patients with scapular dyskinesia who exhibited signs of dyskinesia for at least 6 months before enrolment in the study will be selected.

Exclusion Criteria:

1. History of shoulder or thorax trauma or surgery.
2. The back pain involved the cervical spine and thoracic spine.
3. Participants with neurologic deficits
4. history of inflammatory conditions such as ankylosing spondylitis

4- Certain situations where shockwave therapy is not recommended. These include:

Absolute contraindications:

* Active infection (i.e., osteomyelitis)
* Malignant tumors, particularly at the treatment site (focused shockwave)
* Pregnancy

Relative Contraindications:

* The brain or nerve in the treatment focus
* Treatment focused on the lungs or pleura
* Significant coagulopathy (increased risk of bleeding, such as haemophilia)
* Epiphyseal plate in treatment focus

Important considerations:

* Cardiac pacemakers or other implantable devices
* Current nonsteroidal anti-inflammatory drug use
* Current anticoagulation use
* Recent corticosteroid injections (receiving a steroid injection into the area to be treated within the previous 12 weeks).

Where it's running

  • Tanta University
    Tanta, Egypt
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.